186 related articles for article (PubMed ID: 9108224)
21. [Giant pelvic lipoma mimicking a liposarcoma].
Dhouha B; Maroua W; Seifeddine B; Ghofrane T; Lassaad G; Rached B; Rgaya M
Pan Afr Med J; 2019; 33():20. PubMed ID: 31312336
[TBL] [Abstract][Full Text] [Related]
22. Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors.
Suster S; Fisher C
Am J Surg Pathol; 1997 Feb; 21(2):195-200. PubMed ID: 9042286
[TBL] [Abstract][Full Text] [Related]
23. Update on Lipomatous Tumors with Emphasis on Emerging Entities, Unusual Anatomic Sites, and Variant Histologic Patterns.
Chrisinger JSA
Surg Pathol Clin; 2019 Mar; 12(1):21-33. PubMed ID: 30709444
[TBL] [Abstract][Full Text] [Related]
24. Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases.
Azumi N; Curtis J; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1987 Mar; 11(3):161-83. PubMed ID: 3826477
[TBL] [Abstract][Full Text] [Related]
25. [Subcutaneous and intramuscular atypical lipoma and well differentiated retroperitoneal liposarcoma].
Cutrona D; Greco P
Pathologica; 1981; 73(1026):579-88. PubMed ID: 7031573
[No Abstract] [Full Text] [Related]
26. Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status.
Knebel C; Neumann J; Schwaiger BJ; Karampinos DC; Pfeiffer D; Specht K; Lenze U; von Eisenhart-Rothe R; Rummeny EJ; Woertler K; Gersing AS
BMC Cancer; 2019 Apr; 19(1):309. PubMed ID: 30943944
[TBL] [Abstract][Full Text] [Related]
27. Liposarcoma Preoperatively Diagnosed as Lipoma: 10-Year Experience at a Single Institution.
Sato D; Suga H; Takushima A
Dermatol Surg; 2018 Aug; 44(8):1065-1069. PubMed ID: 29659409
[TBL] [Abstract][Full Text] [Related]
28. Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma: a reappraisal of 30 cases formerly classified as well differentiated liposarcoma.
Evans HL; Soule EH; Winkelmann RK
Cancer; 1979 Feb; 43(2):574-84. PubMed ID: 421182
[TBL] [Abstract][Full Text] [Related]
29. Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.
Worawattanakul S; Semelka RC; Noone TC; Calvo BF; Kelekis NL; Woosley JT
Magn Reson Imaging; 1998 Nov; 16(9):993-1003. PubMed ID: 9839983
[TBL] [Abstract][Full Text] [Related]
30. MR imaging of liposarcomas: correlation of MR features and histology.
London J; Kim EE; Wallace S; Shirkhoda A; Coan J; Evans H
J Comput Assist Tomogr; 1989; 13(5):832-5. PubMed ID: 2778141
[TBL] [Abstract][Full Text] [Related]
31. Magnetic Resonance Imaging Assessment of Lipomatous Soft-tissue Tumors.
Coran A; Ortolan P; Attar S; Alberioli E; Perissinotto E; Tosi AL; Montesco MC; Rossi CR; Tropea S; Rastrelli M; Stramare R
In Vivo; 2017; 31(3):387-395. PubMed ID: 28438867
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of lipomatous soft tissue tumors by MR imaging.
Gelineck J; Keller J; Myhre Jensen O; Nielsen OS; Christensen T
Acta Radiol; 1994 Jul; 35(4):367-70. PubMed ID: 8011387
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of cytology for diagnosis of lipomatous tumors: comparison with magnetic resonance and computed tomography findings in 175 cases.
Einarsdóttir H; Skoog L; Söderlund V; Bauer HC
Acta Radiol; 2004 Dec; 45(8):840-6. PubMed ID: 15690614
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of gadolinium enhancement in differentiating ALT/WD liposarcomas from benign fatty tumors.
Panzarella MJ; Naqvi AH; Cohen HE; Damron TA
Skeletal Radiol; 2005 May; 34(5):272-8. PubMed ID: 15742204
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of lipoma and atypical lipomatous tumor by a scoring system: implication of increased vascularity on pathogenesis of liposarcoma.
Nagano S; Yokouchi M; Setoguchi T; Ishidou Y; Sasaki H; Shimada H; Komiya S
BMC Musculoskelet Disord; 2015 Feb; 16():36. PubMed ID: 25879189
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
37. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
Ross MR; Schomer DF; Chappell P; Enzmann DR
AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
[TBL] [Abstract][Full Text] [Related]
38. [Gadolinium-DTPA combined with a fat suppression technique in studies with magnetic resonance at 0.5 T in soft-tissue neoplasms].
Battolla L; Zampa V; Mascalchi M; Falaschi F; Bagnolesi P; Tessa C; Paolicchi A; Bartolozzi C
Radiol Med; 1994 Oct; 88(4):353-8. PubMed ID: 7997603
[TBL] [Abstract][Full Text] [Related]
39. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
[TBL] [Abstract][Full Text] [Related]
40. Retroperitoneal liposarcoma: MR characteristics and pathological correlative analysis.
Song T; Shen J; Liang BL; Mai WW; Li Y; Guo HC
Abdom Imaging; 2007; 32(5):668-74. PubMed ID: 17387533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
